MTCYBP43

Across TCGA pan-cancer cohorts, MTCYBP43 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTCYBP43’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MTCYBP43 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTCYBP43 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

LUAD, STAD, and LUSC are the cancer types where MTCYBP43 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCYBP43 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.115	.038	1	view →
STAD	All	All	−0.060	.029	1	view →
LUSC	All	All	+0.015	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MTCYBP43–LUAD

Open the LUAD breakdown →